Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
Peter Würtz, Qin Wang, Pasi Soininen, et al.
Journal of the American College of Cardiology (2016) Vol. 67, Iss. 10, pp. 1200-1210
Open Access | Times Cited: 186

Showing 1-25 of 186 citing articles:

Triangulation in aetiological epidemiology
Debbie A. Lawlor, Kate Tilling, George Davey Smith
International Journal of Epidemiology (2016), pp. dyw314-dyw314
Open Access | Times Cited: 990
Recent Developments in Mendelian Randomization Studies
Jie Zheng, Denis Baird, Maria Carolina Borges, et al.
Current Epidemiology Reports (2017) Vol. 4, Iss. 4, pp. 330-345
Open Access | Times Cited: 872
The druggable genome and support for target identification and validation in drug development
Chris Finan, Anna Gaulton, Felix Alexander Krüger, et al.
Science Translational Medicine (2017) Vol. 9, Iss. 383
Open Access | Times Cited: 675
Commentary: Two-sample Mendelian randomization: opportunities and challenges
Debbie A. Lawlor
International Journal of Epidemiology (2016) Vol. 45, Iss. 3, pp. 908-915
Open Access | Times Cited: 651
Mendelian randomization in cardiometabolic disease: challenges in evaluating causality
Michael V. Holmes, Mika Ala‐Korpela, George Davey Smith
Nature Reviews Cardiology (2017) Vol. 14, Iss. 10, pp. 577-590
Open Access | Times Cited: 580
Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies
Peter Würtz, Antti J. Kangas, Pasi Soininen, et al.
American Journal of Epidemiology (2017) Vol. 186, Iss. 9, pp. 1084-1096
Open Access | Times Cited: 492
Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke
Michael V. Holmes, Iona Y. Millwood, Christiana Kartsonaki, et al.
Journal of the American College of Cardiology (2018) Vol. 71, Iss. 6, pp. 620-632
Open Access | Times Cited: 392
Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
François Mach, Kausik K. Ray, Olov Wiklund, et al.
European Heart Journal (2018) Vol. 39, Iss. 27, pp. 2526-2539
Open Access | Times Cited: 332
Mendelian Randomization Study of ACLY and Cardiovascular Disease
Brian A. Ference, Kausik K. Ray, Alberico L. Catapano, et al.
New England Journal of Medicine (2019) Vol. 380, Iss. 11, pp. 1033-1042
Open Access | Times Cited: 281
Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank
Heli Julkunen, Anna Cichońska, Mika Tiainen, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 228
Quantitative Lipoprotein Subclass and Low Molecular Weight Metabolite Analysis in Human Serum and Plasma by 1H NMR Spectroscopy in a Multilaboratory Trial
Beatriz Jiménez, Elaine Holmes, Clement Heude, et al.
Analytical Chemistry (2018) Vol. 90, Iss. 20, pp. 11962-11971
Open Access | Times Cited: 191
Improving the odds of drug development success through human genomics: modelling study
Aroon D. Hingorani, Valerie Kuan, Chris Finan, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 181
Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation
Tom G. Richardson, Genevieve M Leyden, Qin Wang, et al.
PLoS Biology (2022) Vol. 20, Iss. 2, pp. e3001547-e3001547
Open Access | Times Cited: 179
Mendelian randomization for studying the effects of perturbing drug targets
Dipender Gill, Marios K. Georgakis, Venexia Walker, et al.
Wellcome Open Research (2021) Vol. 6, pp. 16-16
Open Access | Times Cited: 176
Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development
Michael V. Holmes, Tom G. Richardson, Brian A. Ference, et al.
Nature Reviews Cardiology (2021) Vol. 18, Iss. 6, pp. 435-453
Open Access | Times Cited: 143
Association of Antihypertensive Drug Target Genes With Psychiatric Disorders
Solal Chauquet, Zhihong Zhu, Michael O’Donovan, et al.
JAMA Psychiatry (2021) Vol. 78, Iss. 6, pp. 623-623
Open Access | Times Cited: 109
Mendelian randomization for studying the effects of perturbing drug targets
Dipender Gill, Marios K. Georgakis, Venexia Walker, et al.
Wellcome Open Research (2021) Vol. 6, pp. 16-16
Open Access | Times Cited: 108
Genome-wide characterization of circulating metabolic biomarkers
Minna K. Karjalainen, Savita Karthikeyan, Clare Oliver‐Williams, et al.
Nature (2024) Vol. 628, Iss. 8006, pp. 130-138
Open Access | Times Cited: 79
Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol
Patrick R. Lawler, Akintunde O. Akinkuolie, Audrey Y. Chu, et al.
Journal of the American Heart Association (2017) Vol. 6, Iss. 7
Open Access | Times Cited: 127
Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration
Johanna M. Colijn, Anneke I. den Hollander, Ayşe Demirkan, et al.
Ophthalmology (2018) Vol. 126, Iss. 3, pp. 393-406
Open Access | Times Cited: 127
Advances in lipid-lowering therapy through gene-silencing technologies
Børge G. Nordestgaard, Stephen J. Nicholls, Anne Langsted, et al.
Nature Reviews Cardiology (2018) Vol. 15, Iss. 5, pp. 261-272
Closed Access | Times Cited: 125
NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects
Eeva Sliz, Sylvain Sebért, Peter Würtz, et al.
Human Molecular Genetics (2018) Vol. 27, Iss. 12, pp. 2214-2223
Open Access | Times Cited: 124
Remnant lipoproteins
Anette Varbo, Børge G. Nordestgaard
Current Opinion in Lipidology (2017) Vol. 28, Iss. 4, pp. 300-307
Closed Access | Times Cited: 112
Metabolic characterization of menopause: cross-sectional and longitudinal evidence
Qin Wang, Diana L. Santos Ferreira, Scott M. Nelson, et al.
BMC Medicine (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 103
Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population
Anette Varbo, Børge G. Nordestgaard
Annals of Neurology (2019) Vol. 85, Iss. 4, pp. 550-559
Open Access | Times Cited: 97
Page 1 - Next Page

Scroll to top